Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations ...

The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...

The US drug regulator has missed a deadline for granting full approval to Novavax's COVID-19 vaccine, the company said ...

The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...

The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.

A ground-breaking research project looking to find a treatment for symptoms of long Covid is underway, as the nation marks ...

Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...

Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 ...